Nathanael Caveney resolves receptor–ligand architectures and signaling mechanisms with cryo‑EM/X‑ray to inform therapeutic design. He engineers cytokine and phosphatase ligands, develops bioconjugate vaccines, and defines bacterial cell‑wall targets for anti‑infective and immunomodulatory applications.